BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22485147)

  • 1. Tanshinones inhibit the growth of breast cancer cells through epigenetic modification of Aurora A expression and function.
    Gong Y; Li Y; Abdolmaleky HM; Li L; Zhou JR
    PLoS One; 2012; 7(4):e33656. PubMed ID: 22485147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactive tanshinones in Salvia miltiorrhiza inhibit the growth of prostate cancer cells in vitro and in mice.
    Gong Y; Li Y; Lu Y; Li L; Abdolmaleky H; Blackburn GL; Zhou JR
    Int J Cancer; 2011 Sep; 129(5):1042-52. PubMed ID: 20848589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive tanshinone I inhibits the growth of lung cancer in part via downregulation of Aurora A function.
    Li Y; Gong Y; Li L; Abdolmaleky HM; Zhou JR
    Mol Carcinog; 2013 Jul; 52(7):535-43. PubMed ID: 22389266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells.
    Fiskus W; Hembruff SL; Rao R; Sharma P; Balusu R; Venkannagari S; Smith JE; Peth K; Peiper SC; Bhalla KN
    Breast Cancer Res Treat; 2012 Sep; 135(2):433-44. PubMed ID: 22825030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer.
    Ma ZL; Zhang BJ; Wang DT; Li X; Wei JL; Zhao BT; Jin Y; Li YL; Jin YX
    Oncotarget; 2015 Aug; 6(24):20111-20. PubMed ID: 26036635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel histone deacetylase 8-selective inhibitor 1,3,4-oxadiazole-alanine hybrid induces apoptosis in breast cancer cells.
    Pidugu VR; Yarla NS; Bishayee A; Kalle AM; Satya AK
    Apoptosis; 2017 Nov; 22(11):1394-1403. PubMed ID: 28840369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive biomarkers of sensitivity to the aurora and angiogenic kinase inhibitor ENMD-2076 in preclinical breast cancer models.
    Diamond JR; Eckhardt SG; Tan AC; Newton TP; Selby HM; Brunkow KL; Kachaeva MI; Varella-Garcia M; Pitts TM; Bray MR; Fletcher GC; Tentler JJ
    Clin Cancer Res; 2013 Jan; 19(1):291-303. PubMed ID: 23136197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tanshinones from Chinese medicinal herb Danshen (Salvia miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling.
    Zhang Y; Won SH; Jiang C; Lee HJ; Jeong SJ; Lee EO; Zhang J; Ye M; Kim SH; Lü J
    Pharm Res; 2012 Jun; 29(6):1595-608. PubMed ID: 22281759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of telomerase activity and activation of caspase-3 are responsible for Tanshinone I-induced apoptosis in monocyte leukemia cells in vitro.
    Liu XD; Fan RF; Zhang Y; Yang HZ; Fang ZG; Guan WB; Lin DJ; Xiao RZ; Huang RW; Huang HQ; Liu PQ; Liu JJ
    Int J Mol Sci; 2010 May; 11(6):2267-80. PubMed ID: 20640151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinone I induces human colorectal cancer cell apoptosis: The potential roles of Aurora A-p53 and survivin-mediated signaling pathways.
    Lu M; Wang C; Wang J
    Int J Oncol; 2016 Aug; 49(2):603-10. PubMed ID: 27279458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suberoylanilide hydroxamic acid-induced specific epigenetic regulation controls Leptin-induced proliferation of breast cancer cell lines.
    Feng X; Han H; Zou D; Zhou J; Zhou W
    Oncotarget; 2017 Jan; 8(2):3364-3379. PubMed ID: 27926517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines.
    Lavarone E; Puppin C; Passon N; Filetti S; Russo D; Damante G
    Mol Cell Endocrinol; 2013 Jan; 365(1):1-10. PubMed ID: 22982218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MS-275, a histone deacetylase inhibitor, induces apoptosis and alters survivin gene expression in human myeloma cell line U266].
    Ma J; Zhao M; Yu XD; Wang ZH
    Ai Zheng; 2009 May; 28(5):466-71. PubMed ID: 19624872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Aurora-B kinase activity by poly(ADP-ribosyl)ation in response to DNA damage.
    Monaco L; Kolthur-Seetharam U; Loury R; Murcia JM; de Murcia G; Sassone-Corsi P
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14244-8. PubMed ID: 16179389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line.
    Wang XX; Liu R; Jin SQ; Fan FY; Zhan QM
    Cell Res; 2006 Apr; 16(4):356-66. PubMed ID: 16617331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly (ADP-ribose) polymerases inhibitor, Zj6413, as a potential therapeutic agent against breast cancer.
    Zhou Q; Ji M; Zhou J; Jin J; Xue N; Chen J; Xu B; Chen X
    Biochem Pharmacol; 2016 May; 107():29-40. PubMed ID: 26920250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kinesin Eg5 inhibitor K858 induces apoptosis but also survivin-related chemoresistance in breast cancer cells.
    De Iuliis F; Taglieri L; Salerno G; Giuffrida A; Milana B; Giantulli S; Carradori S; Silvestri I; Scarpa S
    Invest New Drugs; 2016 Aug; 34(4):399-406. PubMed ID: 26994617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
    Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ
    Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salinomycin induces apoptosis and senescence in breast cancer: upregulation of p21, downregulation of survivin and histone H3 and H4 hyperacetylation.
    Al Dhaheri Y; Attoub S; Arafat K; Abuqamar S; Eid A; Al Faresi N; Iratni R
    Biochim Biophys Acta; 2013 Apr; 1830(4):3121-35. PubMed ID: 23352703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential anti-proliferative activities of poly(ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer cells.
    Chuang HC; Kapuriya N; Kulp SK; Chen CS; Shapiro CL
    Breast Cancer Res Treat; 2012 Jul; 134(2):649-59. PubMed ID: 22678161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.